Targeted metabolomics and medication classification data from participants in the ADNI1 cohort

Alzheimer’s disease (AD) is the most common neurodegenerative disease presenting major health and economic challenges that continue to grow. Mechanisms of disease are poorly understood but significant data point to metabolic defects that might contribute to disease pathogenesis. The Alzheimer Diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: St John-Williams, Lisa, Blach, Colette, Toledo, Jon B., Rotroff, Daniel M., Kim, Sungeun, Klavins, Kristaps, Baillie, Rebecca, Han, Xianlin, Mahmoudiandehkordi, Siamak, Jack, John, Massaro, Tyler J., Lucas, Joseph E., Louie, Gregory, Motsinger-Reif, Alison A., Risacher, Shannon L., Saykin, Andrew J., Kastenmüller, Gabi, Arnold, Matthias, Koal, Therese, Moseley, M. Arthur, Mangravite, Lara M., Peters, Mette A., Tenenbaum, Jessica D., Thompson, J. Will, Kaddurah-Daouk, Rima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Data Descriptor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644370/
https://www.ncbi.nlm.nih.gov/pubmed/29039849
http://dx.doi.org/10.1038/sdata.2017.140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644370/
https://www.ncbi.nlm.nih.gov/pubmed/29039849
http://dx.doi.org/10.1038/sdata.2017.140

Ejemplares similares